Natco Pharma stock rises 3% after subsidiary invests $8 mn in biotech firm
Natco Pharma share price rose after the company on Wednesday announced that its wholly owned Canadian subsidiary, NATCO Pharma Inc, has made an investment of $8 million in eGenesis